The Dissociative Subtype of PTSD – Shared Decision-Making for PTSD – CEUnits

MFT / LCSW

The Dissociative Subtype of PTSD - Shared Decision-Making for PTSD

1.00 - CE credit hours training

$10.00 - Cost of course

This page contains important information about the course, including training details, a comprehensive course description, learning objectives, and source references. We encourage you to review each section to gain a clear understanding of the course content, educational goals, and supporting materials before beginning your training and taking the POST TEST below.

Target audience and instructional level of this course: foundational
There is no known conflict of interest or commercial support related to this CE program.

The Dissociative Subtype of PTSD - Shared Decision-Making for PTSD

Course Training

CLICK LINKS BELOW TO READ MATERIAL

The Dissociative Subtype of PTSD: An Update of the Literature 3537

Shared Decision-making for PTSD 2448

Post Test

10 Questions

1. Patients with PTSD+DS may have which of the following symptoms,suggesting a potential need to stabilize symptoms prior to initiating an exposure-based treatment:

a. Greater severity of illness b. More comorbidity c. Wide range of dissociative symptoms d. All of the above

2. PTSD+DS is associated with complex, polysymptomatic presentations including:

a. severe PTSD symptoms (particularly re-experiencing and hyperarousal symptoms) b. alcoholism and substance abuse c. high levels of childhood maltreatment d. A and C e. A and B

3. True or False: PTSD+DS may be associated more with childhood and/or sexual trauma

a. True b. False

4. PTSD+DS is associated with which of the following neurobiological correlates?

a. decreased prefrontal activity in response to consciously perceived threat. b. decreased connectivity between the BNST and the claustrum, which may be involved in conscious awareness and sensory integration. c. greater resting functional connectivity between the amygdala and prefrontal regions involved in emotion modulation and limbic inhibition, including the ventromedial prefrontal cortex. d. increased functional connectivity between the anterior cerebellum and vermis and areas involved in somatosensory processing, multisensory integration, and bodily self-consciousness.

5. Why is further research examining patients with PTSD+DS warranted?

a. The current literature on treatment response in PTSD+DS is heterogeneous. b. Additional components of treatment could potentially further improve outcome. c. PTSD+DS patients can tolerate and respond to exposure-based treatments and typically end treatment with lower overall symptom severity. d. Experts are dissatisfied with the existing research.

6. What is shared decision-making?

a. A system where patients do their own research and choose their treatment plan based on treatment options, outcomes and side effects. b. A process by which providers and patients collaborate to arrive at an informed treatment plan based on good evidence, accurate expectations, and the patients' personal values. c. A process by which providers determine a patient's treatment plan based on treatment options, outcomes and side effects. d. None of the above

7. In the "option talk" phase of shared decision-making, providers often use which of the following decision aids?

a. Peer presentation b. Magazine c. Video d. Medical journals

8. Shared decision-making has been linked with:

a. greater confidence in the treatment decision b. improved satisfaction with decision-making and with treatment c. greater self-efficacy d. increased trust in the provider e. all of the above

9. Why do practice guidelines recommend shared decision-making for PTSD?

a. There is overwhelming research on its empirical benefits. b. Patients have the right to be informed about their PTSD treatment options and to have a voice in their treatment decisions. c. Veterans prefer unilateral decisions. d. It requires no training for providers to effectively engage.

10. What needs to be done for shared decision-making to become more prevalent with PTSD patients?

a. A shift in provider perspectives on how treatment decisions should be made. b. More resources and decision aids to help providers educate patients about PTSD treatment options. c. Well-designed trials evaluating the impact of shared decision-making on outcomes related to both decision-making and PTSD treatment. d. All of the above

Course Description

Improve your practice with this course on the Dissociative Subtype of Post-Traumatic Stress Disorder (PTSD). In recent years, compelling evidence has emerged that PTSD+DS represents a distinct clinical population with distinct neurobiological and epidemiological features. PTSD+DS, in addition to meeting full criteria for PTSD, captures people who additionally respond to trauma-related stimuli with dissociative symptoms (depersonalization or derealization) and association emotional detachment. This comes in addition to the two dissociative symptoms contained in the core diagnostic criteria for PTSD: dissociative flashbacks and dissociative amnesia.

This course aims to provide guidelines for therapy as well as a summary of the material that has been published on the unique characteristics of this subpopulation. Additionally, the course examines collaborative decision-making interventions and their applications in clinical practice.

Learning Objectives

Summarize the correlates of the dissociative subtypes of PTSD
Summarize the neurobiological correlates of the dissociative subtype of PTSD
Identify treatment implications when dissociation accompanies PTSD
Describe shared decision-making interventions for working with clients with PTSD
Summarize the benefits of shared decision-making interventions for PTSD

Source

Francesca L. Schiavone- Department of Psychiatry, University of Toronto

Paul Frewen, PhD- Department of Psychiatry, University of Western Ontario Department of Psychology, University of Western Ontario

Margaret McKinnon, PhD- Mood Disorders Program, St. Joseph's Healthcare, Department of Psychiatry and Behavioural Neuroscience, McMaster University and Homewood Research Institute

Ruth A. Lanius, MD, PhD- Department of Psychiatry, University of Western Ontario Department of Neuroscience, University of Western Ontario

Juliette Harik, PhD- National Center for PTSD

Published by: National Center for PTSD

MFT / LCSW